Search research articles
Contact Us
Filters
Showing results (131-140 of 151) with videos related to
Page
of 16
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
January 12, 2021
Safety, Pharmacokinetic, and Pharmacodynamic Evaluation of a 2'-(2-Methoxyethyl)-D-ribose Antisense Oligonucleotide-Triantenarry <i>N</i>-Acetyl-galactosamine Conjugate that Targets the Human Transmembrane Protease Serine 6
Thomas A Zanardi, Birgit Korbmacher, Laura Boone, et al.
Carcinogenesis
|
June 1, 1992
Genetic alterations in the 61st codon of the H-ras oncogene isolated from archival sections of hepatic hyperplasias, adenomas and carcinomas in control groups of B6C3F1 mouse bioassay studies conducted from 1979 to 1986
K K Richardson, L M Helvering, D M Copple, et al.
Cancer Letters
|
July 30, 1993
Expression of TRPM-2 during involution and regeneration of the rat liver
L M Helvering, K K Richardson, D M Horn, et al.
Regulatory Toxicology and Pharmacology : RTP
|
November 23, 2024
Carcinogenicity assessment of inotersen in Tg.rasH2 mice and Sprague-Dawley rats: Implications for 2'-MOE antisense oligonucleotides
Tae-Won Kim, Chris N Papagiannis, Laura S Zwick, et al.
Toxicologic Pathology
|
June 8, 2002
Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety
John L Vahle, Masahiko Sato, Gerald G Long, et al.
Antimicrobial Agents and Chemotherapy
|
June 1, 1995
The PETT series, a new class of potent nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase
C Ahgren, K Backro, F W Bell, et al.
Toxicologic Pathology
|
February 28, 2015
Scientific and Regulatory Policy Committee Points-to-consider Paper*: Drug-induced Vascular Injury Associated with Nonsmall Molecule Therapeutics in Preclinical Development: Part I. Biotherapeutics
Kendall S Frazier, Jeffery A Engelhardt, Pierluigi Fant, et al.
Toxicologic Pathology
|
February 27, 2015
Scientific and Regulatory Policy Committee Points-to-consider Paper*: Drug-induced Vascular Injury Associated with Nonsmall Molecule Therapeutics in Preclinical Development: Part 2. Antisense Oligonucleotides
Jeffery A Engelhardt, Pierluigi Fant, Silvia Guionaud, et al.
Journal of Veterinary Medicine. B, Infectious Diseases and Veterinary Public Health
|
April 25, 2006
A virological survey in migrating waders and other waterfowl in one of the most important resting sites of Germany
A Hlinak, R U Mühle, O Werner, et al.
Toxicologic Pathology
|
December 27, 2018
Comparison of the Class Effects of Antisense Oligonucleotides in CByB6F1-Tg(HRAS)2Jic and CD-1 Mice
Tae-Won Kim, Chris N Papagiannis, Laura S Zwick, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 151) with videos related to
Sort By:
Page
of 16
The Journal of Pharmacology and Experimental Therapeutics
|
January 12, 2021
Safety, Pharmacokinetic, and Pharmacodynamic Evaluation of a 2'-(2-Methoxyethyl)-D-ribose Antisense Oligonucleotide-Triantenarry <i>N</i>-Acetyl-galactosamine Conjugate that Targets the Human Transmembrane Protease Serine 6
Thomas A Zanardi, Birgit Korbmacher, Laura Boone, et al.
Carcinogenesis
|
June 1, 1992
Genetic alterations in the 61st codon of the H-ras oncogene isolated from archival sections of hepatic hyperplasias, adenomas and carcinomas in control groups of B6C3F1 mouse bioassay studies conducted from 1979 to 1986
K K Richardson, L M Helvering, D M Copple, et al.
Cancer Letters
|
July 30, 1993
Expression of TRPM-2 during involution and regeneration of the rat liver
L M Helvering, K K Richardson, D M Horn, et al.
Regulatory Toxicology and Pharmacology : RTP
|
November 23, 2024
Carcinogenicity assessment of inotersen in Tg.rasH2 mice and Sprague-Dawley rats: Implications for 2'-MOE antisense oligonucleotides
Tae-Won Kim, Chris N Papagiannis, Laura S Zwick, et al.
Toxicologic Pathology
|
June 8, 2002
Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety
John L Vahle, Masahiko Sato, Gerald G Long, et al.
Antimicrobial Agents and Chemotherapy
|
June 1, 1995
The PETT series, a new class of potent nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase
C Ahgren, K Backro, F W Bell, et al.
Toxicologic Pathology
|
February 28, 2015
Scientific and Regulatory Policy Committee Points-to-consider Paper*: Drug-induced Vascular Injury Associated with Nonsmall Molecule Therapeutics in Preclinical Development: Part I. Biotherapeutics
Kendall S Frazier, Jeffery A Engelhardt, Pierluigi Fant, et al.
Toxicologic Pathology
|
February 27, 2015
Scientific and Regulatory Policy Committee Points-to-consider Paper*: Drug-induced Vascular Injury Associated with Nonsmall Molecule Therapeutics in Preclinical Development: Part 2. Antisense Oligonucleotides
Jeffery A Engelhardt, Pierluigi Fant, Silvia Guionaud, et al.
Journal of Veterinary Medicine. B, Infectious Diseases and Veterinary Public Health
|
April 25, 2006
A virological survey in migrating waders and other waterfowl in one of the most important resting sites of Germany
A Hlinak, R U Mühle, O Werner, et al.
Toxicologic Pathology
|
December 27, 2018
Comparison of the Class Effects of Antisense Oligonucleotides in CByB6F1-Tg(HRAS)2Jic and CD-1 Mice
Tae-Won Kim, Chris N Papagiannis, Laura S Zwick, et al.
Page
of 16